Patents by Inventor Mikihiko KOGO

Mikihiko KOGO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230381275
    Abstract: [Problem] The present invention addresses the problem of providing a muscle function-improving agent for suppressing or improving the decline of muscular functions due to aging. [Solution] Provided is a muscle function-improving agent for suppressing or improving the functional decline of skeletal muscle due to aging, the muscle function-improving agent containing, as an active ingredient, at least one peptide selected from among the following (1)-(3), or a salt thereof: (1) a peptide consisting of the amino acid sequence represented by SEC) ID NO: 1; (2) a peptide which is the fragment of human osteopontin, and in which the C-terminal amino acid sequence is the amino acid sequence represented by SEQ ID NO: 1; and (3) a peptide which consists of an amino acid sequence obtained by substituting, adding, or deleting one or more amino acids in the amino acid sequence of the peptide in (1) or (2), and has the action of suppressing or ameliorating the functional decline of skeletal muscle due to aging.
    Type: Application
    Filed: October 22, 2021
    Publication date: November 30, 2023
    Inventors: Susumu TANAKA, Yoshinosuke HAMADA, Mikihiko KOGO, Hirofumi YAMAMOTO, Naomasa KAWAGUCHI
  • Patent number: 11077167
    Abstract: The present invention provides an agent for promoting skeletal muscle injury repair which agent comprises at least one peptide selected from the following (1) to (4): (1) a peptide consisting of the amino acid sequence of SEQ ID NO: 1, (2) a peptide consisting of the amino acid sequence of SEQ ID NO: 2, (3) a peptide consisting of the amino acid sequence of SEQ ID NO: 3, and (4) a peptide which is a human osteopontin fragment and has the amino acid sequence of SEQ ID NO: 1, 2, or 3 at the C-terminus, or a salt thereof as an active ingredient.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: August 3, 2021
    Assignee: OSAKA UNIVERSITY
    Inventors: Susumu Tanaka, Mikihiko Kogo, Hirofumi Yamamoto, Naomasa Kawaguchi, Yoshinosuke Hamada
  • Publication number: 20200206300
    Abstract: The present invention provides an agent for promoting skeletal muscle injury repair which agent comprises at least one peptide selected from the following (1) to (4): (1) a peptide consisting of the amino acid sequence of SEQ ID NO: 1, (2) a peptide consisting of the amino acid sequence of SEQ ID NO: 2, (3) a peptide consisting of the amino acid sequence of SEQ ID NO: 3, and (4) a peptide which is a human osteopontin fragment and has the amino acid sequence of SEQ ID NO: 1, 2, or 3 at the C-terminus, or a salt thereof as an active ingredient.
    Type: Application
    Filed: June 12, 2018
    Publication date: July 2, 2020
    Applicant: Osaka University
    Inventors: Susumu TANAKA, Mikihiko KOGO, Hirofumi YAMAMOTO, Naomasa KAWAGUCHI, Yoshinosuke HAMADA